CRSP - Bluebird secures up to $175M financing amid gene therapy launches
2024-03-18 11:02:46 ET
More on bluebird bio
- Bluebird Bio: Innovative Therapies, Monetary Setbacks
- Biotech And Pharma Diversification Pays Off
- bluebird bio's Lyfgenia: Navigating Commercialization Challenges In SCD
- Biggest stock movers today: EQT, MESO, Crypto-linked stocks, and more
- bluebird bio shares jump on first outcomes-based Medicaid deal for sickle cell therapy